| Product Code: ETC8540104 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Hereditary Angioedema Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Hereditary Angioedema Market - Industry Life Cycle |
3.4 Netherlands Hereditary Angioedema Market - Porter's Five Forces |
3.5 Netherlands Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) among healthcare professionals and patients |
4.2.2 Growing investment in research and development for new HAE treatments |
4.2.3 Rising prevalence of HAE in the Netherlands |
4.3 Market Restraints |
4.3.1 High cost associated with HAE treatments |
4.3.2 Limited access to specialized healthcare services for HAE patients in certain regions of the Netherlands |
5 Netherlands Hereditary Angioedema Market Trends |
6 Netherlands Hereditary Angioedema Market, By Types |
6.1 Netherlands Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Netherlands Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Netherlands Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Netherlands Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Netherlands Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Netherlands Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Netherlands Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Netherlands Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Netherlands Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Netherlands Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Netherlands Hereditary Angioedema Market Export to Major Countries |
7.2 Netherlands Hereditary Angioedema Market Imports from Major Countries |
8 Netherlands Hereditary Angioedema Market Key Performance Indicators |
8.1 Average time to diagnosis for HAE patients in the Netherlands |
8.2 Number of clinical trials conducted for new HAE treatments in the country |
8.3 Percentage of HAE patients receiving appropriate and timely treatment in the Netherlands |
9 Netherlands Hereditary Angioedema Market - Opportunity Assessment |
9.1 Netherlands Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Hereditary Angioedema Market - Competitive Landscape |
10.1 Netherlands Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here